Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxonidine effects on Neuropeptide Y in hypertension
NCT05147753Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Jan 2010
- Primary completion
- Jun 2014
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of moxonidine in hypertension (HTN), sponsored by Aristotle University of Thessaloniki. Started Jan 2010; status: completed.
02
Drugs
moxonidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05147753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05147753.